Bank Of New York Mellon Corp Bio Sig Technologies, Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$3.99 - $5.53 $3,906 - $5,413	-979 Reduced 1.53%	62,889 $271,000
Q4 2020 Feb 09, 2021	BUY	$2.99 - $5.79 $17,778 - $34,427	5,946 Added 10.27%	63,868 $249,000
Q3 2020 Nov 12, 2020	BUY	$4.79 - $9.1 $1,690 - $3,212	353 Added 0.61%	57,922 $285,000
Q2 2020 Aug 12, 2020	BUY	$3.61 - $11.84 $52,345 - $171,680	14,500 Added 33.67%	57,569 $414,000
Q1 2020 May 06, 2020	SELL	$2.56 - $6.14 $1,856 - $4,451	-725 Reduced 1.66%	43,069 $180,000
Q4 2019 Feb 14, 2020	BUY	$5.78 - $8.11 $13,877 - $19,472	2,401 Added 5.8%	43,794 $259,000
Q3 2019 Nov 07, 2019	BUY	$6.55 - $9.36 $47,284 - $67,569	7,219 Added 21.12%	41,393 $341,000
Q2 2019 Aug 12, 2019	BUY	$5.92 - $9.47 $202,310 - $323,627	34,174 New	34,174 $321,000

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $65.4M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.